IP Library Granted Patent US 12,173,011
Granted Patent B2
US 12,173,011 · App. 18/496,049 · Granted Dec 24, 2024

Compounds and methods of their manufacturing

Inventors: Jacob Westman (Järlåsa, SE); Catarina Malmberg (Uppsala, SE)
Assignee: DICOT PHARMA AB
C07D493/18
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,173,011
App. No.
18/496,049
Granted
Dec 24, 2024
Kind
B2
Abstract

The present document is directed to methods for producing therapeutically active limonoids as well as new limonoid-type compounds.

Claims (10)

1. A method for producing an extract composition of Entandrophragma caudatum prepared from seeds of Entandrophragma caudatum , said extract composition of Entandrophragma caudatum comprising a compound according to Formula IIa, wherein the extract composition of Entandrophragma caudatum is produced by the steps of:

i) mixing ground seeds of Entandrophragma caudatum with methanol, filtering, collecting and concentrating to obtain a concentrated methanol extract;

ii) mixing the concentrated methanol extract with a less polar solvent and a more polar solvent to obtain a two-phase composition and discarding the more polar solvent phase to eliminate polar impurities and concentrating the less polar solvent phase, thereby obtaining the extract composition of Entandrophragma caudatum

wherein R 1 is a straight, branched or cyclic alkyl group with 1 to 6 carbon atoms that is unsubstituted or substituted with OH or a halogen, and

wherein R 2 and R 3 independently are selected from straight, branched or cyclic, substituted or unsubstituted alkyl groups with 1 to 6 carbons or from a nicotinyl group.

2. The method according to claim 1 , wherein the less polar solvent in step (ii) forms an azeotrope with water.

3. The method according to claim 2 , wherein the less-polar solvent comprises ethyl acetate and the polar solvent comprises water.

4. The method according to claim 3 , wherein the less polar solvent is ethyl acetate and the more polar solvent is water, and wherein ethyl acetate and water are present in a volume ratio of 2:1.

5. The method according to claim 1 , wherein the extract composition comprises phragmalin-3,30-di-isobutyrate, phragmalin-3-isobutyrate-30-proprionate, or phragmalin-3-nicotinate-30-isobutyrate, or a combination thereof.

6. The method according to claim 1 , wherein the less polar solvent phase is concentrated by distillation.

Assignments (2)
CHANGE OF NAME Recorded Sep 5, 2024
From: DICOT AB
To: DICOT PHARMA AB
Reel/Frame 068849/0292 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 29, 2024
From: WESTMAN, JACOB; MALMBERG, CATARINA
To: DICOT AB
Reel/Frame 068440/0689 →
Priority Claims (1)
SE 2251130-7 · Sep 30, 2022 · national
Continuity (2)
Continuation 18469860 · Sep 19, 2023
Related Publication 20240124482A1 · Apr 18, 2024